Emilia Rippa

Ceinge Biotecnologie Avanzate (Italy)

Papers

1

Total Citations

25

H-Index

1

About

Dr. Emilia Rippa is a leading geneticist whose research has significantly advanced the molecular understanding of cystic fibrosis (CF), particularly in Southern Italy. Her seminal work, "Molecular epidemiology of cystic fibrosis mutations and haplotypes in southern Italy evaluated with an improved semiautomated robotic procedure" (1996, 25 citations), established her as a pioneer in high-throughput genetic screening. In this study, Dr. Rippa developed a novel semiautomated allele-specific oligonucleotide (ASO) dot blot procedure using multiplex PCR to screen for 22 CF mutations, including delta F508, N1303K, and G542X, in 69 patients. This methodological innovation dramatically improved the efficiency and accuracy of CF mutation detection, enabling comprehensive molecular epidemiology analyses. Her contributions have been instrumental in characterizing the unique CF mutation spectrum in Southern Italy, revealing distinct haplotype patterns that differ from Northern European populations. This work has profound implications for genetic counseling, prenatal diagnosis, and personalized treatment strategies for CF patients in the Mediterranean region. Dr. Rippa’s research exemplifies how technological innovation in molecular diagnostics can transform our understanding of population-specific genetic diseases, ultimately improving clinical outcomes for affected individuals.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Molecular epidemiology of cystic fibrosis mutations and haplotypes in southern Italy evaluated with an improved semiautomated robotic procedure.
25 citations · 1996
📈 Most Prolific Year: 1996 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Ceinge Biotecnologie Avanzate (Italy)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago